S.Korea secures 20,000 courses of Merck's COVID-19 pill, says PM

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New JerseySEOUL - South Korea has secured 20,000 courses of an experimental antiviral pill developed by Merck & Co for COVID-19 treatment, Prime Minister Kim Boo-kyum said on Wednesday, joining other Asian nations rushing to snap up supplies.

Merck also announced on Wednesday a supply and purchase agreement with Singapore https://www.reuters.com/business/healthcare-pharmaceuticals/merck-says-deal-signed-with-singapore-covid-19-antiviral-pill-2021-10-06, following Australia https://www.reuters.com/world/asia-pacific/australia-buy-300000-doses-mercks-covid-19-antiviral-pill-2021-10-04, while Thailand, Taiwan and Malaysia said they are in talks to buy it.

Molnupiravir, on its way to be the first oral antiviral medication for COVID-19, could halve the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19. Merck is seeking approval by the U.S. Food and Drug Administration for the pill."We already have secured a budget enough for treatment of around 40,000 people and have signed a pre-purchase deal for 20,000 courses," Kim told a COVID-19 response meeting on Wednesday.

The Korea Disease Control and Prevention Agency had said it was also in talks with Pfizer and Swiss drugmaker Roche Holding AG, who are also racing to develop an easy-to-administer antiviral pill https://www.reuters.com/business/healthcare-pharmaceuticals/covid-19-pill-developers-aim-top-merck-pfizer-efforts-2021-09-28 for COVID-19.

South Korean government had allocated 36.2 billion won in budget for oral antiviral pills to cure COVID-19. It has been managing its mortality rate - 0.78% as of Tuesday - and critical cases at a fairly low rate.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

South Korea secures 20,000 courses of Merck's COVID-19 pill, says PMSEOUL: South Korea has secured 20,000 courses of an experimental antiviral pill developed by Merck \u0026 Co for COVID-19 treatment, Prime Minister Kim Boo-kyum said on Wednesday (Oct 6), joining other Asian nations rushing to snap up supplies. Merck also announced on Wednesday a supply and purchase agreeme
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Husband of wife who sued to demand ivermectin treatment has died of Covid-19The man died in an intensive care unit on 25 September. He had been diagnosed with COVID-19 in July and as his condition worsened, his wife had grown increasingly desperate to save him.
Source: YahooSG - 🏆 3. / 71 Read more »

Natural immunity vs. COVID-19 vaccine: Which is stronger?One of the arguments against the COVID-19 vaccine mandates is that immunity from a previous coronavirus infection should count as an alternative to vaccination. This topic has received a lot of attention of late, with NBA players and health care workers speaking out and citing “natural immunity” as what they believe to be a valid reason for refusing to get the shot.   However, health experts in the U.S. say immunity through vaccination is the best way to protect people who have had COVID-19 from reinfection. Dr. Peter Hotez, co-director of the Center for Vaccine Development at Texas Children’s Hospital, explains why.
Source: YahooSG - 🏆 3. / 71 Read more »